Skip to main content
. Author manuscript; available in PMC: 2018 Sep 23.
Published in final edited form as: ChemMedChem. 2016 Oct 5;11(21):2410–2421. doi: 10.1002/cmdc.201600417

Figure 4.

Figure 4

Inhibitory effects of the novel prodrugs in comparison with the respective free TKI on RTK signaling. A) Sunitinib-sensitive A431 and B) erlotinib-hypersensitive PC-9 cells were grown in medium with fetal calf serum (FCS) and treated with the indicated drug for 4 h. They were then harvested and lysed, and the impact on ERK phosphorylation as a read out for RTK signaling was analyzed by western blotting. Sun = sunitinib, Erlo = erlotinib, N = normoxia, H = hypoxia.